Trial
NCT07029971
A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Vial Australia Pty Ltd
Collaborators
—
Condition
Ulcerative Colitis (UC)
Intervention
BB-TL1A-VIAL-HLE
Why stopped
Study terminated based on interim analysis results indicating the primary pharmacokinetic endpoint was unlikely to be met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-22